Status:
UNKNOWN
Empowerment of Lung and Heart-lung Transplant Patients
Lead Sponsor:
Hannover Medical School
Conditions:
Lung Transplantation
Heart-Lung Transplantation
Eligibility:
All Genders
18-68 years
Phase:
NA
Brief Summary
Lung or combined heart-lung transplantation represents an established treatment strategy for patients with end-stage lung disease. Transplantation results in an increased exercise capacity, a better q...
Eligibility Criteria
Inclusion
- All individuals following lung or combined heart-lung transplantation at Hanover Medical School
Exclusion
- Severe bronchus stenosis after surgery
- Uncontrolled hypertension
- Orthopedic impairment
- Oxygen desaturation during exercise to less than 89 % without supplemental oxygen
- Cardiovascular complications that limit exercise tolerance
- Persistent multi-drug resistant infections (MRSA, VRE, Burkholderia Cepacia, Pandorea)
- Severe psychiatric disorders
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2014
Estimated Enrollment :
132 Patients enrolled
Trial Details
Trial ID
NCT00808600
Start Date
October 1 2009
End Date
January 1 2014
Last Update
August 19 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hannover Medical School
Hanover, Germany, 30625